Print

Purpose

This prospective longitudinal study will follow participants with Multifocal Motor Neuropathy over time and collect data on their clinical outcomes, quality of life, and use of health care resources. Participants will follow their regular visit schedule with their treating physician, except for an optional second visit occurring 7 to 14 days after the start of the study to collect biomarker data. No IMP will be administered.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Is at least the local legal age of consent for clinical studies when signing the ICF - Is capable of providing signed informed consent and complying with protocol requirements - Has an existing or new diagnosis of MMN made by a neuromuscular specialist or neurologist

Exclusion Criteria

  • Is currently participating in any clinical study with an IMP - Has other medical conditions that could affect the assessment of MMN

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Recruiting Locations

The University of Kansas Health System - Landon Center on Aging
Kansas City, Kansas 66103
Contact:
Mamatha Pasnoor, MD
857-350-4834
clinicaltrials@argenx.com

More Details

Status
Recruiting
Sponsor
argenx

Study Contact

Sabine Coppieters, MD
857-350-4834
ClinicalTrials@argenx.com

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.